|
CTDSP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87500004411589E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15270024028769E-10 |
| Normal-vs-Stage2 |
1.95370000000139E-06 |
| Normal-vs-Stage3 |
1.230440E-02 |
| Normal-vs-Stage4 |
2.713400E-01 |
| Stage1-vs-Stage2 |
7.004600E-01 |
| Stage1-vs-Stage3 |
1.512810E-01 |
| Stage1-vs-Stage4 |
3.290400E-01 |
| Stage2-vs-Stage3 |
3.107800E-01 |
| Stage2-vs-Stage4 |
5.835000E-01 |
| Stage3-vs-Stage4 |
9.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81549997257946E-10 |
| Normal-vs-AfricanAmerican |
5.237700E-04 |
| Normal-vs-Asian |
1.553810E-01 |
| Caucasian-vs-AfricanAmerican |
9.556100E-02 |
| Caucasian-vs-Asian |
9.952200E-01 |
| AfricanAmerican-vs-Asian |
5.688800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8955004232879E-10 |
| Normal-vs-Female |
1.338620E-03 |
| Male-vs-Female |
3.327600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63980999999813E-05 |
| Normal-vs-Extreme_Weight |
3.76789710543335E-11 |
| Normal-vs-Obese |
6.752500E-04 |
| Normal-vs-Extreme_Obese |
2.22320000187182E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.644600E-01 |
| Normal_Weight-vs-Obese |
2.191200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.239220E-01 |
| Extreme_Weight-vs-Obese |
2.030000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.101000E-01 |
| Obese-vs-Extreme_Obese |
8.737500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.372400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.03500000000023E-05 |
| Normal-vs-Age(61-80Yrs) |
8.69371241662975E-12 |
| Normal-vs-Age(81-100Yrs) |
9.980700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.202400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.603100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.177520E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.158400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.776210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.481600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51239998302799E-09 |
| Normal-VS-Type2 PRCC |
3.27182725357034E-12 |
| Normal-VS-KIRP CIMP |
1.514630E-01 |
| Normal-VS-Unclassified PRCC |
2.407800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.703800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.38050000000079E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.820000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.63749999951379E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.356200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.657500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.31820176575116E-11 |
| Normal-vs-N1 |
3.486000E-01 |
| Normal-vs-N2 |
6.740600E-01 |
| N0-vs-N1 |
1.287990E-02 |
| N0-vs-N2 |
6.050300E-02 |
| N1-vs-N2 |
9.678400E-01 |
|
|
